Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.
Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check5 days agoChange DetectedA new 'Locations' section with state listings was added; individual state location subsections and the HHS Vulnerability Disclosure section were removed.SummaryDifference2%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check41 days agoChange DetectedThe funding-status notice and its operating-status guidance have been removed from the page.SummaryDifference0.2%
- Check55 days agoChange DetectedNo substantive content changes detected; the page sections such as Overview, Eligibility Criteria, Plan, and Locations appear the same, with only minor visual or formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check84 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference3%
- Check91 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%
Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.